You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
The Authors' reply
  1. Daniel E Stange1,2,
  2. Bernhard Radlwimmer1
  1. 1Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
  2. 2Department of Surgery, University of Heidelberg, Heidelberg, Germany
  1. Correspondence to Dr B Radlwimmer, Division of Molecular Genetics, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; b.radlwimmer{at}dkfz.de

https://doi.org/10.1136/gut.2010.234435

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We would like to thank Mr Adrian Jubb and his colleagues for sharing their interesting findings.1 In our opinion their data provide additional support for our study2 but fall short of sufficiently addressing the question of the correlation between 11p15.5 DNA copy number gain and ASCL2 expression in liver metastases of colorectal cancer.

    Consistent with our findings, Jubb et al did not detect copy number aberrations on chromosome band 11p15.5 in two additional sets of primary colorectal cancers (pCRC). Nevertheless, over-expression of ASCL2 RNA was …

    View Full Text

    Footnotes

    • Linked article 231746.

    • Competing interests None.

    • Provenance and peer review Not commissioned; not externally peer reviewed.

    Linked Articles